Premium
Evidence for successful treatment in glaucoma: who to treat and when?
Author(s) -
Gandolfi S.
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2017.01522
Subject(s) - glaucoma , modalities , medicine , presentation (obstetrics) , therapeutic modalities , optometry , treatment modality , intensive care medicine , inclusion (mineral) , ophthalmology , physical therapy , psychology , surgery , social science , sociology , social psychology
Summary Treating glaucoma successfully means avoiding the occurrence of visual disability in the individual patient. Since the rate of vision loss can be extremely variable among patients, an accurate phenotyping is essential in planning the proper therapy for each patient. Besides, the recent inclusion of patients’ reported outcomes ( PRO s), in the glaucoma therapeutic algorithm, is increasing the complexity of the scenario. This presentation will focus, then, on (a) the available tools to phenotype the glaucoma patient(s), (b) the criteria for assessing the intensity and the timing of different treatment modalities and (c) the state‐of‐the‐art in the evaluation of PRO s in glaucoma.